Streptozotocin-induced diabetes modulates the metabolic activation of chemical carcinogens
Authors:
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 68 (3-4) , 189-202
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Cytosolic potentiation of the rat hepatic microsome mediated mutagenicity of benzidineMutagenesis, 1987
- Decrease in the levels of a constitutive cytochrome P-450 (RLM5) in hepatic microsomes of diabetic ratsBiochemical and Biophysical Research Communications, 1987
- Metabolic activation of 2-amino-3-methylimidazo(4, 5-f)quinoline by hepatic preparations — contribution of the cytosolic fraction and its significance to strain differencesMutagenesis, 1986
- Cholesterol 7α-hydroxylase of rat liver: An insulin sensitive enzymeBiochemical and Biophysical Research Communications, 1984
- Potentiation of the hepatotoxicity of N-nitrosodimethylamine by fasting, diabetes, acetone, and isopropanolToxicology and Applied Pharmacology, 1984
- N-hydroxylation of carcinogenic and mutagenic aromatic amines.Environmental Health Perspectives, 1983
- Purification and characterization of liver microsomal cytochromes P-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or .beta.-naphthoflavoneBiochemistry, 1982
- Altered Activity of Hepatic Mixed-Function Monooxygenase Enzymes in Streptozotocin-induced Diabetic RatsXenobiotica, 1978
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- SPECIES DIFFERENCE IN DRUG METABOLISM BY LIVER MICROSOMES IN ALLOXAN DIABETIC OR FASTED ANIMALS (II) THE SUBSTRATE INTERACTION WITH CYTOCHROME P-450 IN DRUG OXIDATIONThe Japanese Journal of Pharmacology, 1970